This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

G. P. Anzola, MD; G. Dalla Volta, MD
Clinica Neurologica 2 Divisione Neurologia Universita Brescia Spedali Civili 25125 Brescia, Italy

G. Balestrieri, MD
Servizio di Immunologia Clinica Spedali Civili di Brescia Brescia, Italy

Arch Neurol. 1988;45(10):1061-1062.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Systemic lupus erythematosus (SLE) is probably the systemic disease with the greatest rate of neurologic complications, the pathogenesis of which is still a matter of debate. The estimated rate of such complications ranges between 30% and 70% of all patients affected by SLE. The headache, whether in isolation or associated with other neurologic disturbances, is probably the most common complaint of patients with SLE, and accounts for about half of the referrals of patients with SLE to our clinic.

We have studied both the frequency and the clinical and instrumental features of headache in 82 consecutive patients affected by SLE, who are being followed up by the clinical immunology department of the Spedali Civili of Brescia (Italy). Thirty-four of 82 patients complained of recurrent attacks of headache. They were all women, with a mean age of 32 years (SD, 5). Standard electroencephalographic and computed tomographic scans were . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?